Information Journal Paper
APA:
Copy. (2020). Angiotensinconverting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic. DIABETES & METABOLIC SYNDROME: CLINICAL RESEARCH & REVIEWS, 14(4), 349-350. SID. https://sid.ir/paper/698497/en
Vancouver:
Copy. Angiotensinconverting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic. DIABETES & METABOLIC SYNDROME: CLINICAL RESEARCH & REVIEWS[Internet]. 2020;14(4):349-350. Available from: https://sid.ir/paper/698497/en
IEEE:
Copy, “Angiotensinconverting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic,” DIABETES & METABOLIC SYNDROME: CLINICAL RESEARCH & REVIEWS, vol. 14, no. 4, pp. 349–350, 2020, [Online]. Available: https://sid.ir/paper/698497/en